Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome (Q37091901)
Jump to navigation
Jump to search
scientific article published on July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome |
scientific article published on July 2016 |
Statements
1 reference
Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome (English)
1 reference
David T Miller
1 reference
Mark W Kieran
1 reference
Leslie B Gordon
1 reference
Ralph B D'Agostino
1 reference
Nicole J Ullrich
1 reference
Joe Massaro
1 reference
Monica E Kleinman
1 reference
Heather Shappell
1 reference
Marie Gerhard-Herman
1 reference
Leslie B Smoot
1 reference
Catherine M Gordon
1 reference
Robert H Cleveland
1 reference
Ara Nazarian
1 reference
Brian D Snyder
1 reference
V Michelle Silvera
1 reference
Marilyn G Liang
1 reference
Nicolle Quinn
1 reference
Susanna Y Huh
1 reference
Anne A Dowton
1 reference
Kelly Littlefield
1 reference
Maya M Greer
1 reference
Identifiers
1 reference